Cabaletta Bio, Inc. Set to Engage at Key Investor Conferences

Cabaletta Bio

PHILADELPHIA, PACabaletta Bio, Inc. (Nasdaq: CABA) has announced its participation in a series of influential investor conferences this September.

The company will engage with investors through a series of fireside chats, beginning with the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York, followed by the Wells Fargo Healthcare Conference on September 5 in Boston.

Further interactions will continue at the H.C. Wainwright 26th Annual Global Investment Conference on September 11, also in New York, and conclude with the Cantor Fitzgerald Global Healthcare Conference on September 17.

Each session will feature live webcasts, accessible via Cabaletta Bio’s website, ensuring stakeholders can stay informed. Recordings will be available for replay for 30 days, providing ample opportunity for investors and interested parties to stay updated on the company’s strategic insights and developments.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Gaudenzia's 2024 FrontLine Report Highlights Key Trends in Substance Use Disorder Treatment